Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors
Michael A. Pulsipher(Children's Hospital of Los Angeles), Thomas R. Spitzer(Harvard University), Brandon Hayes‐Lattin(Oregon Health & Science University), John M. McCarty(Virginia Commonwealth University), Vinod K. Prasad(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Deidre M. Kiefer(National Marrow Donor Program), Rebecca Drexler(National Marrow Donor Program), Paul Shaughnessy(CHRISTUS Transplant Institute), Indira Sahdev(Cohen Children's Medical Center), RaeAnne M. Besser(National Marrow Donor Program), Hati Kobusingye(National Marrow Donor Program), Kimberly A. Kasow(University of North Carolina at Chapel Hill), Brent R. Logan(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Carolyn Bigelow(Jackson Memorial Hospital), Theresa Hahn, Ann A. Jakubowski(Memorial Sloan Kettering Cancer Center), Parameswaran Hari(Medical College of Wisconsin), Ibrahim Ahmed(Children's Mercy Hospital), Michael Linenberger(Fred Hutch Cancer Center), Hillard M. Lazarus(University Hospitals Cleveland Medical Center), Christopher C. Dvorak(University of California, San Francisco), Joseph P. McGuirk(University of Kansas Medical Center), Andrew Artz, Witold B. Rybka(Penn State Milton S. Hershey Medical Center), Scott D. Rowley(Johns Hopkins Hospital), David A. Jacobsohn(Center for Cancer and Blood Disorders), Jane L. Liesveld(Strong Memorial Hospital), Ruthee-Lu Bayer(North Shore University Hospital), Margarida Magalhaes‐Silverman(University of Iowa Hospitals and Clinics), Ann E. Haight, J. Douglas Rizzo, Paolo Anderlini(The University of Texas MD Anderson Cancer Center), Pintip Chitphakdithai(National Marrow Donor Program), Vinod Parameswaran(Avera McKennan Hospital & University Health Center), Shahram Mori(Florida Hospital Cancer Institute), O’Susan F. Leitman(National Institutes of Health Clinical Center), Shalini Shenoy(St. Louis Children's Hospital), Jeffrey Schriber, Aly Abdel‐Mageed(Helen DeVos Children's Hospital), Mark R. Litzow(Toyota Motor Corporation (Switzerland)), Walter Longo(UW Health University Hospital), Brian J. Bolwell(Cleveland Clinic), David Delgado(Indiana University Hospital), Luke P. Akard(Franciscan Health Indianapolis), George B. Selby(University of Oklahoma), Edward D. Ball(Sheba Medical Center), E. Randolph Broun(Jewish Hospital), J. Philip Miller(Washington University in St. Louis), Katharine E. Duckworth(Atrium Health Wake Forest Baptist), Marcie Riches(University of North Carolina at Chapel Hill)
Cited by 22
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.1k
Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent Fever
|New England Journal of Medicine|2002|986